Ming-Feng Xia

4.1k citations
100 papers · 3.2k · 1 hit paper · h-index 30

Impact in

Papers in

Ming-Feng Xia

97 papers receiving 3.2k citations

Ming-Feng Xia's Hit Papers

DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER 2024 · 73 citations
730+1Years since publication204060

Peers

Ming-Feng Xia
Comparison fields: 5 of 91
  • Epidemiology 1.5k
  • Endocrinology, Diabetes and Metabolism 410
  • Pharmacology 323
  • Drug Discovery 4
  • Physiology 274
Replace Hongmei Yan with:
Hongmei Yan China
Hua Bian China
Qing Zhu China
Myoung Sook Han United States
Gouri Ranganathan United States
Birgit Gustafson Sweden
Aina S. Lihn Denmark
Leonard C. Glass United States
Fen Zhuge Japan
Xinxia Chang China
Ming-Feng Xia relative to Hongmei Yan China Hongmei Yan's profile →
Citations per field
00.5×1.5×1.8×
Hongmei Yan · 1×
Citations per year

Countries citing papers authored by Ming-Feng Xia

Since Specialization
Citations

This map shows the geographic impact of Ming-Feng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Feng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Feng Xia more than expected).

Fields of papers citing papers by Ming-Feng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Feng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Feng Xia. The network helps show where Ming-Feng Xia may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming-Feng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming-Feng Xia Line = papers co-authored together Ming-Feng Xia links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019226
2 2015203
3 2016195
4 2017130
5 2011126
6 2019122
7 2019110
8 2020105
9 202098
10 201188
11 201677
12
DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
Hit paper breakdown →
202473
13 202169
14 202164
15 201862
16 201856
17 202052
18 201650
19 201245
20 201244

About Ming-Feng Xia

Ming-Feng Xia is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Physiology, Pharmacology and Orthopedics and Sports Medicine, having authored 100 papers that have together received 3.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (56 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Berberine and alkaloids research (5 papers), Bariatric Surgery and Outcomes (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Genetic Associations and Epidemiology (4 papers), Bone health and osteoporosis research (3 papers) and Vitamin D Research Studies (3 papers). The work is most often cited by research in Epidemiology (1.5k citations), Endocrinology, Diabetes and Metabolism (410 citations), Pharmacology (323 citations), Drug Discovery (4 citations) and Physiology (274 citations). Ming-Feng Xia has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xin Gao, Hua Bian, Hongmei Yan, Xinxia Chang, Huandong Lin, Hui Ma, Xiuzhong Yao, Wanyuan He, Xiaopeng Zhu and Qiqige Aleteng. Their work appears in journals such as Lipids in Health and Disease, PLoS ONE, Journal of Translational Medicine, Obesity and Diabetes/Metabolism Research and Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact